Biomea Fusion Statistics
Share Statistics
Biomea Fusion has 36.24M shares outstanding. The number of shares has increased by 1.41% in one year.
| Shares Outstanding | 36.24M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.74% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 31.63M |
| Failed to Deliver (FTD) Shares | 252 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 8.48M, so 23.39% of the outstanding shares have been sold short.
| Short Interest | 8.48M |
| Short % of Shares Out | 23.39% |
| Short % of Float | 30.13% |
| Short Ratio (days to cover) | 10.78 |
Valuation Ratios
The PE ratio is -4.22 and the forward PE ratio is -2.41.
| PE Ratio | -4.22 |
| Forward PE | -2.41 |
| PS Ratio | 0 |
| Forward PS | 109 |
| PB Ratio | 2.93 |
| P/FCF Ratio | -4.95 |
| PEG Ratio | n/a |
Enterprise Valuation
Biomea Fusion Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 7.84, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.84 |
| Quick Ratio | 7.84 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 1.44 |
| Cash Flow / Debt | -39.17 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.69% and return on capital (ROIC) is -70.26%.
| Return on Equity (ROE) | -0.69% |
| Return on Assets (ROA) | -0.59% |
| Return on Capital (ROIC) | -70.26% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.10M |
| Employee Count | 107 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -60.2% in the last 52 weeks. The beta is -0.43, so Biomea Fusion 's price volatility has been lower than the market average.
| Beta | -0.43 |
| 52-Week Price Change | -60.2% |
| 50-Day Moving Average | 8.76 |
| 200-Day Moving Average | 9.28 |
| Relative Strength Index (RSI) | 30.9 |
| Average Volume (20 Days) | 804.70K |
Income Statement
In the last 12 months, Biomea Fusion had revenue of $0 and earned -$117.25M in profits. Earnings per share was $-3.44.
| Revenue | 0 |
| Gross Profit | -4.20M |
| Operating Income | -126.14M |
| Net Income | -117.25M |
| EBITDA | -124.62M |
| EBIT | - |
| Earnings Per Share (EPS) | -3.44 |
Balance Sheet
The company has $176.87M in cash and $10.30M in debt, giving a net cash position of $166.57M.
| Cash & Cash Equivalents | 176.87M |
| Total Debt | 10.30M |
| Net Cash | 166.57M |
| Retained Earnings | -248.82M |
| Total Assets | 110.42M |
| Working Capital | 66.03M |
Cash Flow
In the last 12 months, operating cash flow was -$96.59M and capital expenditures -$3.37M, giving a free cash flow of -$99.96M.
| Operating Cash Flow | -96.59M |
| Capital Expenditures | -3.37M |
| Free Cash Flow | -99.96M |
| FCF Per Share | -2.93 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
BMEA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -60.99% |
| FCF Yield | -48.91% |
Analyst Forecast
The average price target for BMEA is $23.5, which is 316.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $23.5 |
| Price Target Difference | 316.7% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
Scores
| Altman Z-Score | -4.43 |
| Piotroski F-Score | 2 |